Israel vs Saudi Arabia: HIV-positive TB patients on ART (antiretroviral therapy)
Israel
100.0%
in 2024
Saudi Arabia
100.0%
in 2024
Israel rank
1st
Saudi Arabia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Israel
- Saudi Arabia
How they compare
Israel currently reports 100.0% against 100.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2008 it was Saudi Arabia ahead.
Israel ranks 1st and Saudi Arabia ranks 1st of 144 countries.
Across the 3 decades both report, Israel averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Israel | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 99.0% | 1.0% | Israel |
| 2020s | 98.2% | 100.0% | 1.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Israel or Saudi Arabia?
- Israel, at 100.0% against 100.0% in Saudi Arabia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Israel and Saudi Arabia?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Saudi Arabia?
- 10 years are reported by both, from 2008 to 2024.
- How do Israel and Saudi Arabia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Israel ranks 1st and Saudi Arabia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.